MEDICURE SCIENTIFIC LIMITED

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—4

Registered number: 09260860

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Intangible Assets	4		30,000		45,000

			30,000		45,000
CURRENT ASSETS
Stocks	5	69,000		128,000
Debtors	6	791,707		3,307
Cash at bank and in hand		65,694		786,507

		926,401		917,814
Creditors: Amounts Falling Due Within One Year	7	(340,687 )		(342,693 )

NET CURRENT ASSETS (LIABILITIES)			585,714		575,121

TOTAL ASSETS LESS CURRENT LIABILITIES			615,714		620,121

NET ASSETS			615,714		620,121

CAPITAL AND RESERVES
Called up share capital	8		100		100
Profit and Loss Account			615,614		620,021

SHAREHOLDERS' FUNDS			615,714		620,121

Page 1

Page 2

MEDICURE SCIENTIFIC LIMITED

Balance Sheet (continued)

As At 31 October 2025

For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Baseer Ahmed

Director

20/07/2026

The notes on pages 3 to 4 form part of these financial statements.

1. General Information

MEDICURE SCIENTIFIC LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 09260860 . The registered office is 24 Felbrigge Road, Ilford, IG3 8DN.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

2.3. Intangible Fixed Assets and Amortisation - Other Intangible

Other intangible assets are patent costs It is amortised to the profit and loss account over its estimated economic life of 3 years.

2.4. Stocks and Work in Progress

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

2.5. Taxation

Income tax expense represents the sum of the tax currently payable.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

3. Average Number of Employees

Average number of employees, including directors, during the year was: NIL (2024: NIL)

4. Intangible Assets

	Other
	£
Cost
As at 1 November 2024	45,000

As at 31 October 2025	45,000

Amortisation
As at 1 November 2024	-
Provided during the period	15,000

As at 31 October 2025	15,000

Net Book Value
As at 31 October 2025	30,000

As at 1 November 2024	45,000

Page 3

Page 4

MEDICURE SCIENTIFIC LIMITED

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

5. Stocks

	2025	2024
	£	£
Finished goods	69,000	128,000

6. Debtors

	2025	2024
	£	£
Due within one year
Amounts owed by group undertakings	786,178	-
Other debtors	5,529	3,307

	791,707	3,307

7. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Trade creditors	4,267	4,268
Other creditors	333,935	336,543
Taxation and social security	2,485	1,882

	340,687	342,693

8. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	100	100

9. Related Party Transactions

Included in creditors falling due within one year is an amount of £329,995 (2024: £332,303) owed to the director. The loan is interest free.

Page 4